These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A multicenter, randomized study of an extended cycle oral contraceptive. Anderson FD, Hait H. Contraception; 2003 Aug; 68(2):89-96. PubMed ID: 12954519 [Abstract] [Full Text] [Related]
8. Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial. Anderson FD, Gibbons W, Portman D. Am J Obstet Gynecol; 2006 Jul; 195(1):92-6. PubMed ID: 16813747 [Abstract] [Full Text] [Related]
9. Efficacy and safety of a 28-day oral contraceptive with 7 days of low-dose estrogen in place of placebo. Poindexter A, Reape KZ, Hait H. Contraception; 2008 Aug; 78(2):113-9. PubMed ID: 18672111 [Abstract] [Full Text] [Related]
11. Endometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placebo. Anderson FD, Feldman R, Reape KZ. Contraception; 2008 Feb; 77(2):91-6. PubMed ID: 18226671 [Abstract] [Full Text] [Related]
17. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women. Griffith SG, Dai Y. Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769 [Abstract] [Full Text] [Related]